| --- | --- | |-------------------------------------------------------------|-------| | | | | Q3 2020 results | | | webcast | | | Onno van de Stolpe, CEO Piet Wigerinck, CSO 6 November 2020 | | | | | Disclaimer This presentation contains forward-looking statements, including (without limitation) statements concerning the progress of our clinical pipeline, the statements regarding the global R&D collaboration with Gilead, statements relating to interactions with regulatory authorities, the timing or likeliho ...

Galápagos We discover We dare We care Investor Relations slides | August 2020 1 Disclaimer This presentation contains forward-looking statements, including (without limitation) statements concerning the progress of our clinical pipeline, the statements regarding the global R&D collaboration with Gilead, the amount and timing of potential future milestone, opt-in and/or royalty payments by Gilead, statements relating to interactions with regulatory authorities, the potential approval process for filgotinib a ...

Galapagos NV (NASDAQ:GLPG) Q2 2020 Results Earnings Conference Call August 7, 2020 8:00 AM ET Company Participants Good day, and welcome to the Galapagos Half Year Results Call. At this time, I'd like to turn the conference over to Ms. Elizabeth Goodwin. Please go ahead. Elizabeth Goodwin Thank you all for joining us today for the audio webcast of Galapagos' First Half 2020 Results. I'm Elizabeth Goodwin, Investor Relations, also representing a great reporting team. This recorded webcast is accessible via t ...

Galapagos NV (NASDAQ:GLPG) Q1 2020 Results Conference Call May 8, 2020 8:00 AM ET Company Participants Elizabeth Goodwin - Investor Relations Onno van de Stolpe - CEO Bart Filius - COO and CFO Piet Wigerinck - Chief Scientific Officer Walid Abi-Saab - Chief Medical Officer Michele Manto - Chief Commercial Officer Conference Call Participants Christopher Marai - Nomura Securities Jason Gerberry - Bank of America Evan Seigerman - Credit Suisse Wimal Kapadia - Bernstein Debjit Chattopadhyay - H.C. Wainwright B ...

Galapagos NV (NASDAQ:GLPG) Q4 2019 Earnings Conference Call February 21, 2020 8:00 AM ET Company Participants Elizabeth Goodwin - Vice President, Investor Relations Onno van de Stolpe - Chief Executive Officer Bart Filius - Chief Operating Officer & Chief Financial Officer Walid Abi-Saab - Chief Medical Officer Piet Wigerinck - Chief Scientific Officer Michele Manto - Chief Commercial Officer Conference Call Participants Dane Leone - Raymond James Rushee Jolly - Bernstein Christopher Marai - Nomura Instinet ...

Galapagos NV (NASDAQ:GLPG) Q3 2019 Results Conference Call October 25, 2019 8:00 AM ET Company Participants | --- | |-------------------------------------------| | | | | | Elizabeth Goodwin - VP, IR | | Onno van de Stolpe - CEO | | Bart Filius - COO and CFO | | Walid Abi-Saab - CMO | | Piet Wigerinck - Chief Scientific Officer | | Conference Call Participants | | Eliana Merle - Cantor Fitzgerald | | Brian Abrahams - RBC Capital Markets | | Connor Meehan - Morgan Stanley | | Adam Walsh - Stifel | | Wimal Kap ...

Galapagos NV (NASDAQ:GLPG) Q2 2019 Earnings Conference Call July 26, 2019 8:00 AM ET Company Participants Elizabeth Goodwin - VP, IR & Corporate Communications Onno van de Stolpe - Co-Founder, MD, CEO & Executive Director Bart Filius - CFO & COO Walid Abi-Saab - Chief Medical Officer Conference Call Participants Rushee Jolly - Sanford C. Bernstein & Co. Evan Seigerman - Crédit Suisse Emily Field - Barclays Bank Brian Abrahams - RBC Capital Markets James Quigley - JPMorgan Chase & Co. Eliana Merle - Cantor F ...

Novel targets, better treatments Investor Presentation | June 2019 Disclaimer This presentation contains forward-looking statements, including (without limitation) statements concerning the progress of our clinical pipeline, the slides captioned "We go step by step on commercial" "Prolific late stage pipeline" "R&D ambition" "Filgotinib program" "FINCH summary up to w24" "Filgotinib: promising profile" "Inflammation market ~$65B by 2027" "$2.1B market with large unmet needs" "We are building a fibrosis port ...

Galapagos NV (NASDAQ:GLPG) Q1 2019 Results Earnings Conference Call April 26, 2019 8:00 AM ET Company Participants Elizabeth Goodwin - VP of IR & Corporate Communications Onno van de Stolpe - Chief Executive Officer Bart Filius - CFO & COO Piet Wigerinck - Chief Scientific Officer Walid Abi-Saab - Chief Medical Officer Conference Call Participants Wimal Kapadia - Bernstein Eliana Merle - Cantor Fitzgerald Emily Field - Barclays Debjit Chattopadhyay - H.C. Wainwright James Quigley - JPMorgan Christopher Mara ...

Galapagos NV (NASDAQ:GLPG) Q4 2018 Earnings Conference Call February 22, 2019 8:00 AM ET Company Participants Elizabeth Goodwin - Investor Relations Onno van de Stolpe - Chief Executive Officer Bart Filius - Chief Operating Officer & Chief Financial Officer Walid Abi-Saab - Chief Medical Officer Piet Wigerinck - Chief Scientific Officer Conference Call Participants Brian Abrahams - RBC Capital Markets Wimal Kapadia - Bernstein Christopher Marai - Nomura Edwind Zhang - Stifel Lucy Codrington - Jefferies Phil ...